Economic Analysis in Genomic Medicine

Genomics|Update|Current

Economic Analysis in Genomic Medicine

The Economics of Genomic Medicine: Institute of Medicine workshop summary (2013)

CDC paper: Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility. 
Scott D. Grosse. Genetics in Medicine (2014)  

The economic value of personalized medicine tests: what we know and what we need to know. 
Kathryn A Phillips et al. Genetics in Medicine (2013)  

Selected Recent Economic Analyses:

Cost effectiveness of a 92-gene assay for the diagnosis of metastatic cancer 
Bentley TG, et al. J Med Econ 2014 Apr

Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer 
Roth JA, et al. Oncologist 2014 Apr

Cost-effectiveness of pharmacogenetics-guided warfarin therapy vs. alternative anticoagulation in atrial fibrillation 
Pink J, et al. Clin Pharmacol Ther 2014 Feb;95(2):199-207

Cost-effectiveness analysis of Mammostrat(R) compared with Oncotype DX(R) to inform the treatment of breast cancer 
Mislick K, et al. Clinicoecon Outcomes Res 2014;6:37-47

Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population 
Saokaew S, et al. PLoS One 2014;9(4):e94294

Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome 
Kazi DS, et al. Ann Intern Med 2014 Feb;160(4)